Company intelligence
ATUM
Moving research further, faster.
About ATUM
ATUM is an industry-leading provider of life science tools and solutions. Founded as DNA2.0 in 2003, we were a pioneer in the application of machine learning to synthetic biology and currently hold multiple patents covering several technologies, including our first-to-market Leap-In Transposase® platform. Our integrated offerings include Gene Design & Synthesis, Protein Production, and Cell Line Development — all powered by our Leap-In Transposase® and machine learning platform. This means a streamlined path from sequence to Research Cell Bank (RCB) with just a click, ensuring efficiency, regulatory compliance, and innovative solutions tailored to our clients' needs. ATUM is privately held and is headquartered in Newark, CA.
Verified activity
Signals from ATUM
3 published signals
Presence & Recognition
ATUM received 60 IND filings, highlighting its team and client trust.
Reported by Chava Angell, PhD
Customers & Market
ATUM hit 60 IND filings as of yesterday.
Reported by Mario Ribas
Products & Services
ATUM celebrated the 60th Investigational New Drug (IND) filing for Leap-In Transposase.
Reported by ATUM